Sweet dreams: glycosylation controls tumor cell dormancy.

dormancy extracellular matrix glycosylation metastasis

Journal

Trends in cancer
ISSN: 2405-8025
Titre abrégé: Trends Cancer
Pays: United States
ID NLM: 101665956

Informations de publication

Date de publication:
03 Feb 2024
Historique:
received: 16 01 2024
accepted: 24 01 2024
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 4 2 2024
Statut: aheadofprint

Résumé

In a recent study in Cancer Cell, Sreekumar et al. used therapy-associated breast cancer mouse models as well as in vitro dormancy models to identify extracellular matrix (ECM)-related tumor cell-autonomous mechanisms of dormancy in residual tumor cells (RTCs). The study reveals an important role of the glycosylation of proteoglycans in sustaining dormancy and opens the door to leverage this biology to eliminate RTCs and prevent recurrence.

Identifiants

pubmed: 38311543
pii: S2405-8033(24)00011-6
doi: 10.1016/j.trecan.2024.01.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests No interests are declared.

Auteurs

Erin Bresnahan (E)

Department of Medicine, Division of Hematology and Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY, USA.

Jose Javier Bravo-Cordero (JJ)

Department of Medicine, Division of Hematology and Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY, USA. Electronic address: josejavier.bravo-cordero@mssm.edu.

Classifications MeSH